Bisphosphonates and skeletal morbidity in patients with metastatic cancer

CMAJ. Canadian Medical Association Journal

Volumn 169, Issue 10, 2003, Pages 1053-

  Bhandari, Mohit ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; PLACEBO;

BONE METASTASIS; BREAST CARCINOMA; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RESEARCH; CLINICAL TRIAL; CONFIDENCE INTERVAL; DRUG EFFICACY; HUMAN; HYPERCALCEMIA; MULTIPLE MYELOMA; NOTE; ORTHOPEDIC SURGERY; POPULATION RESEARCH; PROSTATE CARCINOMA; SPINAL CORD COMPRESSION; STATISTICAL SIGNIFICANCE; SURGICAL RISK; TREATMENT OUTCOME; VERTEBRA FRACTURE;

EID: 0344515521     PISSN: 08203946     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (3)

1. Cranney A, Wells G, Willan A, Griffith L, Zytaruk N, Robinson V, et al. Meta-analyses of therapies for postmenopausal osteoporosis. II. Meta-analysis of alendronate for the treatment of postmenopausal women. Endocr Rev 2002;23:508-16.
2. Guyatt GH, Rennie D, editors. User's guides to the medical literature: a manual for evidence-based clinical practice. Chicago: American Medical Association Press; 2002.
3. Montori VM, Swiontkowski MF, Cook DJ. Methodologie issues in systematic reviews and meta-analyses. Clin Orthop 2003;413:43-54.